Isoprostanes as Markers of Lipid Peroxidation in Atherosclerosis
- 1 January 1999
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 91 references indexed in Scilit:
- Prostaglandin F2-Like Compounds, F2-Isoprostanes, Are Present in Increased Amounts in Human Atherosclerotic LesionsArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Macrophage recognition of LDL modified by levuglandin E2, an oxidation product of arachidonic acidBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1997
- Nonenzymatic Free Radical-catalyzed Generation of Thromboxane-like Compounds (Isothromboxanes) in VivoJournal of Biological Chemistry, 1996
- Plasma 8‐epi‐PGF2α levels are elevated in individuals with non‐insulin dependent diabetes mellitusFEBS Letters, 1995
- Effect of in-vivo supplementation with low-dose vitamin E on susceptibility of low-density lipoprotein and high-density lipoprotein to oxidative modification.Journal of the American College of Nutrition, 1995
- Evidence that the F2-isoprostane, 8-epi-prostaglandin F2α, is formed in vivoBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1994
- Vascular Smooth Muscle Actions and Receptor Interactions of 8-Iso-prostaglandin E2, an E2-IsoprostaneBiochemical and Biophysical Research Communications, 1993
- Monitoring vitamin E pools in sheep tissue and plasma after intravenous dosing of radiotocopherolBritish Journal of Nutrition, 1990
- Role of superoxide in endothelial-cell modification of low-density lipoproteinsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1988
- Update on the role of cigarette smoking in coronary artery diseaseAmerican Heart Journal, 1981